Smitaa Patel Selected Research

Disease Progression

11/2011

Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Smitaa Patel Research Topics

Disease

18	Parkinson Disease (Parkinson's Disease) 01/2022 - 06/2010
1	Dementia (Dementias) 09/2014
1	Infections 11/2011
1	Disease Progression 11/2011
1	Helicobacter Infections 11/2011
1	Huntington Disease (Huntington's Disease) 11/2009
1	Chorea (Rheumatic Chorea) 11/2009
1	Mobility Limitation (Difficulty Walking) 09/2009

Drug/Important Bio-Agent (IBA)

6	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 11/2010
4	Monoamine Oxidase (MAO)IBA 01/2022 - 06/2011
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2022 - 09/2014
3	Pharmaceutical PreparationsIBA 09/2014 - 06/2010
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2022
1	propylene diquat (PDQ(+))IBA 01/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2011
1	Antihypertensive Agents (Antihypertensives)IBA 11/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2011
1	Isradipine (Dynacirc)FDA LinkGeneric 11/2011
1	TEMPOIBA 06/2011
1	nabilone (Cesamet)FDA Link 11/2009

Therapy/Procedure

10	Therapeutics 01/2022 - 06/2010
3	Language Therapy (Language Training) 08/2021 - 06/2014
3	Occupational Therapy (Therapy, Occupational) 03/2016 - 09/2009
2	Activities of Daily Living (ADL) 01/2016 - 09/2009
1	Physical Therapy Modalities (Physical Therapy Technique) 08/2012
1	Deep Brain Stimulation 06/2010
1	Terminal Care (Care, Terminal) 09/2009